STALLERGENES GREER ANNOUNCES RESULTS OF 2016 ANNUAL GENERAL MEETING

June 9, 2016

STALLERGENES GREER ANNOUNCES RESULTS OF 2016 ANNUAL GENERAL MEETING

London (United Kingdom) – Stallergenes Greer plc (the “Company”) announced that, at its Annual General Meeting held earlier today in Paris, France, all resolutions set out in the Notice of Meeting sent to shareholders on 3 May 2016 were duly proposed and passed.

Shareholders re-elected Chairman and CEO Fereydoun Firouz, and Directors Stefan Meister, Jean-Luc Bélingard, Patrick Langlois and Paola Ricci – each for a further term of one year. Three new Board members were also elected, including:

  • Rodolfo Bogni as a Non-Executive Director of the Company. Mr. Bogni is Chairman of Northill UK, a director of Waypoint Capital Holdings and a trustee of the Prince of Liechtenstein Foundation and of LGT. He is also a member of the Governing Council of the CSFI (Centre for the Study of Financial Innovation), a member of the Advisory Board of Oxford Analytica and of the Council of Shakespeare’s Globe Theatre.
  • Yvonne Schlaeppi, as an Independent Non-Executive Director of the Company. Ms. Schlaeppi is currently Managing Partner and Co-Founder of Stratevise, a Boston-based strategic and transaction advisory firm active in life sciences. She also serves on the External Advisory Council to the Brigham and Women’s Hospital’s largest research-only division, the Channing Division of Network Medicine, and recently served as independent director on the boards of Greer Laboratories and Ares Allergy Holdings (US).
  • Elmar Schnee, as an Independent Non-Executive Director of the Company. Mr. Schnee is COO of Mindmaze SA, a neuro-technology company. He is also a member of the Board of Directors of Jazz Pharmaceuticals, and serves currently on the board of directors of four privately held life sciences companies.

“I would like to thank our re-elected Directors, Stefan Meister, Jean-Luc Bélingard, Patrick Langlois and Paola Ricci, for their contribution and advice during this first year for Stallergenes Greer, and our shareholders for their continued support,” said Chairman and CEO, Fereydoun Firouz. “I am delighted that Rodolfo Bogni, Yvonne Schlaeppi and Elmar Schnee have decided to join our Board of Directors. Each brings significant knowledge and experience in the biopharmaceutical and financial sectors.”

Mr. Langlois will chair the Audit Committee and Mr. Schnee the Remuneration and Nomination Committees.

The full text of each resolution passed at the Annual General Meeting held earlier today is set out in the Notice of Annual General Meeting which is available for viewing on the Company’s website at www.stallergenesgreer.com